Fresno Hematology and Medical Oncology

Topics

• Genetic factors in colorectal cancer 13
• Cancer Immunotherapy and Biomarkers 10
• Lymphoma Diagnosis and Treatment 7
• Colorectal Cancer Treatments and Studies 6
• Multiple Myeloma Research and Treatments 5
• Prostate Cancer Treatment and Research 5
• Acute Myeloid Leukemia Research 4
• Bladder and Urothelial Cancer Treatments 4
• Gastric Cancer Management and Outcomes 4
• Renal cell carcinoma treatment 4
• Testicular diseases and treatments 4
• Cancer Cells and Metastasis 3

Most cited

1. Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial.

   Lancet (London, England) · 2024 · 148 citations · Haifaa Abdulhaq

2. Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer.

   Annals of oncology : official journal of the European Society for Medical Oncology · 2024 · 76 citations · Priya Jayachandran

3. Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers.

   Journal for immunotherapy of cancer · 2022 · 110 citations · Priya Jayachandran

4. Targeting CNS Metastases in Non-Small Cell Lung Cancer With Evolving Approaches Using Molecular Markers: A Review.

   JAMA oncology · 2025 · 16 citations · Gregory Gilmore

5. Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions.

   Oncogene · 2023 · 37 citations · Priya Jayachandran

6. Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment.

   Oncogene · 2022 · 41 citations · Priya Jayachandran